Milestone Pharmaceuticals INC. (MIST) — 8-K Filings

8-K Filings (23)

• Milestone Pharmaceuticals Files 8-K — Dec 15, 2025 Risk: low
  Milestone Pharmaceuticals Inc. filed an 8-K on December 15, 2025, reporting events that occurred on December 12, 2025. The filing includes information related t
• Milestone Pharmaceuticals Files 8-K on Financials — Aug 12, 2025 Risk: low
  On August 12, 2025, Milestone Pharmaceuticals Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial conditio
• Milestone Pharmaceuticals Inc. Files 8-K for Material Agreement — Jul 14, 2025 Risk: medium
  On July 11, 2025, Milestone Pharmaceuticals Inc. entered into a Material Definitive Agreement. The company, headquartered in Montreal, Quebec, filed an 8-K repo
• Milestone Pharmaceuticals Inc. Files 8-K for Material Agreement — Jul 11, 2025 Risk: medium
  On July 10, 2025, Milestone Pharmaceuticals Inc. entered into a material definitive agreement. The company, headquartered in Montreal, Quebec, filed an 8-K repo
• Milestone Pharmaceuticals Files 8-K — Jun 16, 2025 Risk: low
  Milestone Pharmaceuticals Inc. filed an 8-K on June 16, 2025, reporting other events and financial statements. The company, incorporated in Quebec with its prin
• Milestone Pharmaceuticals Inc. Files 8-K: Board & Compensation Changes — Jun 12, 2025 Risk: medium
  Milestone Pharmaceuticals Inc. announced on June 10, 2025, a change in its board of directors and executive compensation arrangements. The filing also covers th
• Milestone Pharmaceuticals Files 8-K on Financials — May 14, 2025 Risk: low
  Milestone Pharmaceuticals Inc. filed an 8-K on May 14, 2025, reporting on its results of operations and financial condition. The filing includes financial state
• Milestone Pharmaceuticals Files 8-K — Mar 28, 2025 Risk: low
  Milestone Pharmaceuticals Inc. filed an 8-K on March 28, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The filing does not contain spe
• Milestone Pharma Files 8-K on Shareholder Nominations — Mar 19, 2025 Risk: medium
  Milestone Pharmaceuticals Inc. filed an 8-K on March 19, 2025, reporting a shareholder nomination event as of March 18, 2025. The filing details the company's i
• Milestone Pharmaceuticals Files 8-K: Material Agreement — Mar 18, 2025 Risk: medium
  On March 18, 2025, Milestone Pharmaceuticals Inc. filed an 8-K report detailing a material definitive agreement. The filing also includes other events and finan
• Milestone Pharmaceuticals Files 8-K on Financials — Mar 13, 2025 Risk: low
  Milestone Pharmaceuticals Inc. filed an 8-K on March 13, 2025, reporting on its results of operations and financial condition. The filing details the company's
• Milestone Pharmaceuticals Files 8-K Report — Feb 25, 2025 Risk: low
  On February 25, 2025, Milestone Pharmaceuticals Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, as well as a Regulati
• Milestone Pharmaceuticals Files 8-K on Financials — Nov 12, 2024 Risk: low
  Milestone Pharmaceuticals Inc. filed an 8-K on November 12, 2024, reporting on its results of operations and financial condition. The filing includes financial
• Milestone Pharmaceuticals Reports Director/Officer Changes & Shareholder Votes — Sep 4, 2024 Risk: medium
  Milestone Pharmaceuticals Inc. filed an 8-K on September 4, 2024, reporting on events that occurred on August 28, 2024. The filing includes information regardin
• Milestone Pharmaceuticals Files 8-K on Financials — Aug 8, 2024 Risk: low
  On August 8, 2024, Milestone Pharmaceuticals Inc. filed an 8-K report. The filing pertains to the company's results of operations and financial condition, as we
• Milestone Pharmaceuticals Announces Material Agreement and Executive Changes — Jul 15, 2024 Risk: medium
  Milestone Pharmaceuticals Inc. announced on July 14, 2024, that it entered into a material definitive agreement. The company also reported the departure of dire
• Milestone Pharmaceuticals Files 8-K — May 29, 2024 Risk: low
  On May 29, 2024, Milestone Pharmaceuticals Inc. filed an 8-K report. The filing primarily concerns other events and financial statements/exhibits, with no speci
• Milestone Pharmaceuticals Files 8-K Report — May 13, 2024 Risk: low
  On May 13, 2024, Milestone Pharmaceuticals Inc. filed an 8-K report detailing its financial results and operations. The company, incorporated in Quebec, operate
• Milestone Pharmaceuticals Files 8-K — Apr 8, 2024 Risk: low
  Milestone Pharmaceuticals Inc. filed an 8-K on April 8, 2024, reporting "Other Events" and "Financial Statements and Exhibits." The filing does not contain spec
• Milestone Pharmaceuticals Files 8-K — Mar 28, 2024 Risk: low
  On March 28, 2024, Milestone Pharmaceuticals Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," ind
• Milestone Pharmaceuticals Files 8-K on Financials — Mar 21, 2024 Risk: low
  Milestone Pharmaceuticals Inc. filed an 8-K on March 21, 2024, reporting on its results of operations and financial condition. The filing includes financial sta
• Milestone Pharmaceuticals Inc. Files 8-K — Mar 4, 2024 Risk: medium
  On February 28, 2024, Milestone Pharmaceuticals Inc. entered into a material definitive agreement, the details of which are not fully disclosed in this filing.
• Milestone Pharma Files 8-K on Feb 26 for 'Other Event' — Feb 26, 2024 Risk: medium
  Milestone Pharmaceuticals Inc. filed an 8-K on February 26, 2024, reporting an 'Other Event' and 'Financial Statements and Exhibits'. The filing indicates a cur

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX